Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Vincent Le Moing Geneviève Chêne |
| Publication date | December 1, 2000 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |